Inhibition of calcium/calmodulin-dependent protein kinase kinase β and calcium/calmodulin-dependent protein kinase IV is detrimental in cerebral ischemia

Stroke

Volumn 44, Issue 9, 2013, Pages 2559-2566

  McCullough, Louise D ^a   Tarabishy, Sami ^a   Liu, Lin ^a   Benashski, Sharon ^a   Xu, Yan ^a   Ribar, Thomas ^b   Means, Anthony ^b   Li, Jun ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CaMKK and CaMK IV; Cerebral ischemia

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE BETA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; HISTONE DEACETYLASE 4; MATRIX METALLOPROTEINASE; PROTEIN BCL 2; PROTEIN SERINE THREONINE KINASE INHIBITOR; STO 609; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; KNOCKOUT MOUSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

CAMKK Β AND CAMK IV; CEREBRAL ISCHEMIA;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CALCIUM; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 4; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL PATHWAYS;

EID: 84884499260     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001030     Document Type: Article

References (28)

1. Judge SI, Smith PJ, Stewart PE, Bever CT Jr. Potassium channel blockers and openers as CNS neurologic therapeutic agents. Recent Pat CNS Drug Discov. 2007;2:200-228.
2. Horn J, Limburg M. Calcium antagonists for ischemic stroke: a systematic review. Stroke. 2001;32:570-576.
3. Pivovarova NB, Andrews SB. Calcium-dependent mitochondrial function and dysfunction in neurons. FEBS J. 2010;277:3622-3636.
4. Tauskela JS, Morley P. On the role of Ca2+ in cerebral ischemic preconditioning. Cell Calcium. 2004;36:313-322.
5. Zündorf G, Reiser G. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal. 2011;14:1275-1288.
6. Means AR. The year in basic science: calmodulin kinase cascades. Mol Endocrinol. 2008;22:2759-2765.
7. Racioppi L, Means AR. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J Biol Chem. 2012;287:31658-31665.
8. Yano S, Tokumitsu H, Soderling TR. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature. 1998;396:584-587.
9. Wayman GA, Lee YS, Tokumitsu H, Silva AJ, Silva A, Soderling TR. Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron. 2008;59:914-931.
10. Bolger TA, Yao TP. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J Neurosci. 2005;25:9544-9553.
11. Sasaki T, Takemori H, Yagita Y, Terasaki Y, Uebi T, Horike N, et al. SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron. 2011;69:106-119.
12. Kokubo M, Nishio M, Ribar TJ, Anderson KA, West AE, Means AR. BDNF-mediated cerebellar granule cell development is impaired in mice null for CaMKK2 or CaMKIV. J Neurosci. 2009;29:8901-8913.
13. Li J, Benashski SE, Venna VR, McCullough LD. Effects of metformin in experimental stroke. Stroke. 2010;41:2645-2652.
14. Liu F, Akella P, Benashski SE, Xu Y, McCullough LD. Expression of Na-K-Cl cotransporter and edema formation are age dependent after ischemic stroke. Exp Neurol. 2010;224:356-361.
15. Choudhri TF, Hoh BL, Solomon RA, Connolly ES Jr, Pinsky DJ. Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke. 1997;28:2296-2302.
16. Venna VR, Weston G, Benashski SE, Tarabishy S, Liu F, Li J, et al. NF-κB contributes to the detrimental effects of social isolation after experimental stroke. Acta Neuropathol. 2012;124:425-438.
17. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci. 2005;25:6401-6408.
18. Zhang RL, Zhang C, Zhang L, Roberts C, Lu M, Kapke A, et al. Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke. Stroke. 2008;39:2830-2836.
19. Li J, McCullough LD. Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab. 2010;30:480-492.
20. Chen SD, Lin TK, Lin JW, Yang DI, Lee SY, Shaw FZ, et al. Activation of calcium/calmodulin-dependent protein kinase IV and peroxisome proliferator-activated receptor γ coactivator-1α signaling pathway protects against neuronal injury and promotes mitochondrial biogenesis in the hippocampal CA1 subfield after transient global ischemia. J Neurosci Res. 2010;88:3144-3154.
21. Wayman GA, Tokumitsu H, Davare MA, Soderling TR. Analysis of CaM-kinase signaling in cells. Cell Calcium. 2011;50:1-8.
22. Zhao X, Ito A, Kane CD, Liao TS, Bolger TA, Lemrow SM, et al. The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking. J Biol Chem. 2001;276:35042-35048.
23. Bardai FH, D'Mello SR. Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta. J Neurosci. 2011;31:1746-1751.
24. Kitagawa K. CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J. 2007;274:3210-3217.
25. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004;56:468-477.
26. Gaines P, Lamoureux J, Marisetty A, Chi J, Berliner N. A cascade of Ca(2+)/calmodulin-dependent protein kinases regulates the differentiation and functional activation of murine neutrophils. Exp Hematol. 2008;36:832-844.
27. McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci. 2008;28:9451-9462.
28. Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab. 2011;31:52-57.